ABiMed: An intelligent and visual clinical decision support system for medication reviews and polypharmacy management
December 13, 2023 Β· Declared Dead Β· π BMC Medical Informatics and Decision Making
"No code URL or promise found in abstract"
Evidence collected by the PWNC Scanner
Authors
Abdelmalek Mouazer, Romain LΓ©guillon, Nada Boudegzdame, Thibaud Levrard, Yoann Le Bars, Christian Simon, Brigitte SΓ©roussi, Julien Grosjean, Romain Lelong, Catherine Letord, StΓ©fan Darmoni, Matthieu Schuers, Karima Sedki, Sophie Dubois, Hector Falcoff, Rosy Tsopra, Jean-Baptiste Lamy
arXiv ID
2312.11526
Category
cs.HC: Human-Computer Interaction
Cross-listed
cs.AI
Citations
3
Venue
BMC Medical Informatics and Decision Making
Last Checked
4 months ago
Abstract
Background: Polypharmacy, i.e. taking five drugs or more, is both a public health and an economic issue. Medication reviews are structured interviews of the patient by the community pharmacist, aiming at optimizing the drug treatment and deprescribing useless, redundant or dangerous drugs. However, they remain difficult to perform and time-consuming. Several clinical decision support systems were developed for helping clinicians to manage polypharmacy. However, most were limited to the implementation of clinical practice guidelines. In this work, our objective is to design an innovative clinical decision support system for medication reviews and polypharmacy management, named ABiMed. Methods: ABiMed associates several approaches: guidelines implementation, but the automatic extraction of patient data from the GP's electronic health record and its transfer to the pharmacist, and the visual presentation of contextualized drug knowledge using visual analytics. We performed an ergonomic assessment and qualitative evaluations involving pharmacists and GPs during focus groups and workshops. Results: We describe the proposed architecture, which allows a collaborative multi-user usage. We present the various screens of ABiMed for entering or verifying patient data, for accessing drug knowledge (posology, adverse effects, interactions), for viewing STOPP/START rules and for suggesting modification to the treatment. Qualitative evaluations showed that health professionals were highly interested by our approach, associating the automatic guidelines execution with the visual presentation of drug knowledge. Conclusions: The association of guidelines implementation with visual presentation of knowledge is a promising approach for managing polypharmacy. Future works will focus on the improvement and the evaluation of ABiMed.
Community Contributions
Found the code? Know the venue? Think something is wrong? Let us know!
π Similar Papers
In the same crypt β Human-Computer Interaction
R.I.P.
π»
Ghosted
R.I.P.
π»
Ghosted
Improving fairness in machine learning systems: What do industry practitioners need?
R.I.P.
π»
Ghosted
Identifying Stable Patterns over Time for Emotion Recognition from EEG
R.I.P.
π»
Ghosted
Questioning the AI: Informing Design Practices for Explainable AI User Experiences
R.I.P.
π»
Ghosted
Deep Learning for Sensor-based Human Activity Recognition: Overview, Challenges and Opportunities
R.I.P.
π»
Ghosted
Educational data mining and learning analytics: An updated survey
Died the same way β π» Ghosted
R.I.P.
π»
Ghosted
Federated Learning: Strategies for Improving Communication Efficiency
R.I.P.
π»
Ghosted
In-Datacenter Performance Analysis of a Tensor Processing Unit
R.I.P.
π»
Ghosted
Deep Convolutional Neural Networks for Computer-Aided Detection: CNN Architectures, Dataset Characteristics and Transfer Learning
R.I.P.
π»
Ghosted